N. Ferrara, H. P. Gerber, and J. Lecouter, The biology of VEGF and its receptors, Nature Medicine, vol.99, issue.21, pp.669-676, 2003.
DOI : 10.1073/pnas.152324099

I. Flamme, G. Breier, and W. Risau, Vascular Endothelial Growth Factor (VEGF) and VEGF Receptor 2(flk-1) Are Expressed during Vasculogenesis and Vascular Differentiation in the Quail Embryo, Developmental Biology, vol.169, issue.2, pp.699-712, 1995.
DOI : 10.1006/dbio.1995.1180

N. Ferrara, K. J. Hillan, H. P. Gerber, and W. Novotny, Case history: Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer, Nature Reviews Drug Discovery, vol.81, issue.5, pp.391-400, 2004.
DOI : 10.1016/S1359-6349(03)91004-4

M. W. Stewart and M. W. Stewart, Inflammatory Allergy Drug Targets, British Journal of Ophthalmology, vol.10, issue.2012, pp.497-508, 2011.

J. Konner and J. Dupont, S81-85 ; b) Holash, Clinical Colorectal Cancer J, vol.4, issue.2, 2004.

Z. Release and . Aflibercept, Approved in the EU for Patients with Previously Treated Metastatic Colorectal Cancer http

S. P. Ivy, J. Y. Wick, and B. M. Kaufman, An overview of small-molecule inhibitors of VEGFR signaling, Nature Reviews Clinical Oncology, vol.15, issue.10, pp.569-579, 2009.
DOI : 10.1016/S0002-9440(10)65021-3

A. Morabito, E. De-maio, M. Di-maio, N. Normanno, and F. Perrone, Tyrosine Kinase Inhibitors of Vascular Endothelial Growth Factor Receptors in Clinical Trials: Current Status and Future Directions, The Oncologist, vol.11, issue.7, pp.753-764, 2006.
DOI : 10.1634/theoncologist.11-7-753

H. K. Gan, B. Seruga, and J. J. Knox, Sunitinib in solid tumors, Expert Opinion on Investigational Drugs, vol.26, issue.6, pp.821-834, 2009.
DOI : 10.1016/j.jsbmb.2007.09.004

. Release, FDA approves Sutent for rare type of pancreatic cancer

S. M. Wilhelm, L. Adnane, P. Newell, A. Villanueva, J. M. Llovet et al., Molecular Cancer Therapeutics, Acta Pharmacologica Sinica, vol.7, issue.201210, pp.3129-3140, 2008.

F. Approval, FDA Approves Nexavar for Patients with Inoperable Liver Cancer, 2007.

A. D. Becke, The Journal of Chemical Physics, pp.5648-5652, 1993.

P. C. Hariharan and J. A. Pople, The influence of polarization functions on molecular orbital hydrogenation energies, Theoretica Chimica Acta, vol.53, issue.3, pp.213-222, 1973.
DOI : 10.1007/BF00533485

X. Zhang, X. Zhou, R. L. Kisliuk, J. Piraino, V. Cody et al., Design, synthesis, biological evaluation and X-ray crystal structure of novel classical 6,5,6-tricyclic benzo[4,5]thieno[2,3-d]pyrimidines as dual thymidylate synthase and dihydrofolate reductase inhibitors, Bioorganic & Medicinal Chemistry, vol.19, issue.11, pp.3585-3594, 2011.
DOI : 10.1016/j.bmc.2011.03.067

S. G. Dzhavakhishvili, N. Y. Gorobets, S. V. Shishkina, O. V. Shishkin, S. M. Desenko et al., ]pyrimidin-4-one Scaffold via Regioselective Alkylation Reactions, Journal of Combinatorial Chemistry, vol.11, issue.3, pp.508-514, 2009.
DOI : 10.1021/cc9000373

C. E. Stephens, T. M. Felder, J. W. Sowell-sr, G. Andrei, J. Balzarini et al., Synthesis and antiviral/antitumor evaluation of 2-amino- and 2-carboxamido-3-arylsulfonylthiophenes and related compounds as a new class of diarylsulfones, Bioorganic & Medicinal Chemistry, vol.9, issue.5, pp.1123-1132, 2001.
DOI : 10.1016/S0968-0896(00)00333-3

B. A. Hathaway, B. E. Taylor, and J. S. Wittenborn, Selective Preparation of 4-(Bromo or Iodo)-2,5-dimethoxybenzonitrile and 2-(Bromo or Iodo)-3,6-dimethoxybenzonitrile from 2,5-Dimethoxybenzaldehyde, Synthetic Communications, vol.6, issue.24, pp.4629-4637, 1998.
DOI : 10.1016/S0040-4039(01)80650-X

. Partie-expérimentale, Synthèse séquentielle des dérivés urées RMN 1 H (400MHz, DMSO-d 6 ) : ? = 4.99 (s, 2H, pp.93-100

. Partie-expérimentale, Synthèse séquentielle des dérivés urées RMN 1 H (400MHz, DMSO-d 6 ) : ? = 4.02 (s, 2H, p.97

4. Ard, 1. , J. Ard, and 1. , 72 (s, NH urée) (s, NH urée), pp.37-44

. Partie-expérimentale, Synthèse séquentielle des dérivés urées f. 1-(4-Chloro-3-(trifluorométhyl)phényl)-3-(4-(((4-oxo-3,4- dihydrothiéno[2,3-d]pyrimidin-2-yl)méthyl)thio)phényl)urée 71

G. Partie-expérimentale-sommen, A. Comel, G. Kirsch, and G. Sommen, Synthèse séquentielle des dérivés urées 1. 1 a), Synlett, issue.06, pp.855-0857, 2003.

G. Sommen, A. Comel, G. Kirsch, G. Sommen, A. Comel et al., Preparation of thieno[2,3-b]pyrroles starting from ketene-N,S-acetals, Tetrahedron, vol.59, issue.9, pp.1557-1564, 2001.
DOI : 10.1016/S0040-4020(03)00054-1

S. Hesse, E. Perspicace, and G. Kirsch, Microwave-assisted synthesis of 2-aminothiophene-3-carboxylic acid derivatives, 3H-thieno[2,3-d]pyrimidin-4-one and 4-chlorothieno[2,3-d]pyrimidine, Tetrahedron Letters, vol.48, issue.30, pp.5261-5264, 2007.
DOI : 10.1016/j.tetlet.2007.05.136

E. Perspicace, S. Hesse, G. Kirsch, M. Yemloul, and C. Lecomte, ]pyrimidines, Journal of Heterocyclic Chemistry, vol.128, issue.3, pp.459-464, 2009.
DOI : 10.1002/jhet.107

J. Zhang, P. L. Yang, and N. S. Gray, Targeting cancer with small molecule kinase inhibitors, Nature Reviews Cancer, vol.62, issue.1, pp.28-39, 2009.
DOI : 10.1016/S0092-8674(03)00194-6

J. Zhang, Y. Shan, X. Pan, and L. He, Mini-Reviews in Medicinal Chemistry, pp.920-946, 2011.

J. Folkman, Annals of Surgery, pp.409-416, 1972.

E. Perspicace, V. Jouan-hureaux, R. Ragno, F. Ballante, S. Sartini et al., Design, synthesis and biological evaluation of new classes of thieno[3,2-d]pyrimidinone and thieno[1,2,3]triazine as inhibitor of vascular endothelial growth factor receptor-2 (VEGFR-2), European Journal of Medicinal Chemistry, vol.63, pp.765-781, 2013.
DOI : 10.1016/j.ejmech.2013.03.022

URL : https://hal.archives-ouvertes.fr/hal-00826273

D. W. Leung, G. Cachianes, W. J. Kuang, D. V. Goeddel, and N. Ferrara, Vascular endothelial growth factor is a secreted angiogenic mitogen, Science, vol.246, issue.4935, pp.1306-1309, 1989.
DOI : 10.1126/science.2479986

P. Carmeliet, Angiogenesis in life, disease and medicine, Nature, vol.Teill II, issue.7070, pp.932-936, 2005.
DOI : 10.1053/j.seminoncol.2004.03.034

R. Demir, A. Yaba, and B. Huppertz, Vasculogenesis and angiogenesis in the endometrium during menstrual cycle and implantation, Acta Histochemica, vol.112, issue.3, pp.203-214, 2010.
DOI : 10.1016/j.acthis.2009.04.004

M. Klagsbrun, Regulators of Angiogenesis, Annual Review of Physiology, vol.53, issue.1, pp.217-239, 1991.
DOI : 10.1146/annurev.ph.53.030191.001245

E. Perspicace, Etude, synthèse et évaluation de composés en série hétérocyclique à activité inhibitrice

W. Risau and I. Flamme, Vasculogenesis, Annual Review of Cell and Developmental Biology, vol.11, issue.1, pp.73-91, 1995.
DOI : 10.1146/annurev.cb.11.110195.000445

T. Hato, M. Tabata, and Y. Oike, The Role of Angiopoietin-Like Proteins in Angiogenesis and Metabolism, Trends in Cardiovascular Medicine, vol.18, issue.1, pp.6-14, 2008.
DOI : 10.1016/j.tcm.2007.10.003

K. K. Hirschi, S. A. Rohovsky, and P. A. D-'amore, PDGF, TGF-??, and Heterotypic Cell???Cell Interactions Mediate Endothelial Cell???induced Recruitment of 10T1/2 Cells and Their Differentiation to a Smooth Muscle Fate, The Journal of Cell Biology, vol.144, issue.3, pp.805-814, 1998.
DOI : 10.1074/jbc.271.25.15008

M. Arras, W. D. Ito, D. Scholz, B. Winkler, J. Schaper et al., Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb., Journal of Clinical Investigation, vol.101, issue.1, pp.40-50, 1998.
DOI : 10.1172/JCI119877

N. Ferrara, H. P. Gerber, and J. Lecouter, The biology of VEGF and its receptors, Nature Medicine, vol.99, issue.21, pp.669-676, 2003.
DOI : 10.1073/pnas.152324099

N. Rahimi, Vascular endothelial growth factor receptors: Molecular mechanisms of activation and therapeutic potentials, Experimental Eye Research, vol.83, issue.5, pp.1005-1016, 2006.
DOI : 10.1016/j.exer.2006.03.019

B. Faivre, Thérapie anti-angiogénique et risque thrombotique, problème d'actualité, Thèse de Doctorat de l'Université Henri Poincaré Nancy 1, 2008.

G. Bergers and L. E. Benjamin, Angiogenesis: Tumorigenesis and the angiogenic switch, Nature Reviews Cancer, vol.3, issue.6, pp.401-410, 2003.
DOI : 10.1038/nrc1093

Y. Liu, S. R. Cox, T. Morita, and S. Kourembanas, Hypoxia Regulates Vascular Endothelial Growth Factor Gene Expression in Endothelial Cells : Identification of a 5' Enhancer, Circulation Research, vol.77, issue.3, pp.638-643, 1995.
DOI : 10.1161/01.RES.77.3.638

O. Tredan, R. Grantab, and C. Dumontet, L'hypoxie tumorale peut-elle devenir un avantage pour la chimiothérapie ?, p.7, 2008.

J. L. Balligand, eNOS Activation by Physical Forces: From Short-Term Regulation of Contraction to Chronic Remodeling of Cardiovascular Tissues, Physiological Reviews, vol.89, issue.2, pp.481-534, 2009.
DOI : 10.1067/mob.2000.104205

P. Carmeliet, Blood vessels and nerves: common signals, pathways and diseases, Nature Reviews Genetics, vol.107, issue.9, pp.710-720, 2003.
DOI : 10.1046/j.1469-7580.2000.19740591.x

H. Gerhardt, VEGF and endothelial guidance in angiogenic sprouting, Organogenesis, vol.444, issue.4, pp.241-246, 2008.
DOI : 10.1007/978-0-387-78632-2_3

P. Carmeliet, VEGF as a Key Mediator of Angiogenesis in Cancer, Oncology, vol.45, issue.3, pp.4-10, 2005.
DOI : 10.1038/nm988

N. Ferrara and T. Davis-smyth, The Biology of Vascular Endothelial Growth Factor, Endocrine Reviews, vol.18, issue.1, pp.4-25, 1997.
DOI : 10.1210/edrv.18.1.0287

S. Koch and L. Claesson-welsh, Cold Spring Harbor Perspectives in, Medicine, vol.2012, issue.27, pp.6-502

R. D. Meyer, C. Latz, and N. Rahimi, Recruitment and Activation of Phospholipase C??1 by Vascular Endothelial Growth Factor Receptor-2 Are Required for Tubulogenesis and Differentiation of Endothelial Cells, Journal of Biological Chemistry, vol.114, issue.18, pp.16347-16355, 2003.
DOI : 10.1128/MCB.19.7.4961

A. J. Singh, R. D. Meyer, H. Band, and N. Rahimi, The Carboxyl Terminus of VEGFR-2 Is Required for PKC-mediated Down-Regulation, Molecular Biology of the Cell, vol.16, issue.4, pp.2106-2118, 2005.
DOI : 10.1091/mbc.E04-08-0749

K. Holmes, O. L. Roberts, A. M. Thomas, and M. J. Cross, Vascular endothelial growth factor receptor-2: Structure, function, intracellular signalling and therapeutic inhibition, Cellular Signalling, vol.19, issue.10, pp.2003-2012, 2007.
DOI : 10.1016/j.cellsig.2007.05.013

R. Roskoski, Biochemical and Biophysical Research Communications, pp.287-291, 2008.

A. Garofalo, Conception, synthèse et évaluation pharmacologique de nouveaux dérivés quinazoliniques à visée anticancéreuse potentielle, Thèse de Doctorat Université de Lille 2, 2009.

C. Ruch, G. Skiniotis, M. O. Steinmetz, T. Walz, and K. Ballmer-hofer, Structure of a VEGF???VEGF receptor complex determined by electron microscopy, Nature Structural & Molecular Biology, vol.14, issue.3, pp.249-250, 2007.
DOI : 10.1074/jbc.M100763200

T. Takahashi, S. Yamaguchi, K. Chida, and M. Shibuya, A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells, The EMBO Journal, vol.20, issue.11, pp.2768-2778, 2001.
DOI : 10.1093/emboj/20.11.2768

R. D. Meyer, A. Singh, F. Majnoun, C. Latz, K. Lashkari et al., Substitution of C-terminus of VEGFR-2 with VEGFR-1 promotes VEGFR-1 activation and endothelial cell proliferation, Oncogene, vol.23, issue.32, pp.5523-5531, 2004.
DOI : 10.1074/jbc.M209712200

J. Ma and D. J. Waxman, Combination of antiangiogenesis with chemotherapy for more effective cancer treatment, Molecular Cancer Therapeutics, vol.7, issue.12, pp.3670-3684, 2008.
DOI : 10.1158/1535-7163.MCT-08-0715

A. Lièvre, B. Landi, E. Mitry, and J. Taïeb, Les antiangiog??niques en oncologie digestive, Gastroent??rologie Clinique et Biologique, vol.32, issue.5, pp.504-520, 2008.
DOI : 10.1016/j.gcb.2008.01.042

S. T. Crooke, Molecular mechanisms of action of antisense drugs, Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, vol.1489, issue.1, pp.31-44, 1999.
DOI : 10.1016/S0167-4781(99)00148-7

D. Bellet and V. Dangles-marie, Anticorps humanisés en thérapeutique Direction générale des relations culturelles scientifiques et techniques. Médecine sciences M/S. http://EY9TU4HR4B.search.serialssolutions.com/?V=1.0&L=EY9TU4HR4B&S=JCs&C=M SM23SC&T=marc, 2005.

N. Ferrara, K. J. Hillan, H. P. Gerber, and W. Novotny, Case history: Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer, Nature Reviews Drug Discovery, vol.81, issue.5, pp.391-400, 2004.
DOI : 10.1016/S1359-6349(03)91004-4

M. W. Stewart and M. W. Stewart, Inflammatory Allergy Drug Targets, British Journal of Ophthalmology, vol.10, issue.2012, pp.497-508, 2011.

J. Konner, J. Dupont, and R. Leidich, S81-85 ; b) Holash, Clinical Colorectal Cancer J.; Davis, S.; Papadopoulos, N.; Croll, S. D, issue.2, 2004.

Z. Release, S. P. Ivy, J. Y. Wick, and B. M. Kaufman, Approved in the EU for Patients with Previously Treated Metastatic Colorectal Cancer http://en.sanofi.com/Images/31840_20130205_ZALTRAP_en.pdf, Nature Reviews Clinical Oncology Oncologist Angiogenesis, vol.86, issue.131, pp.569-579, 2006.

H. K. Gan, B. Seruga, and J. J. Knox, Sunitinib in solid tumors, Expert Opinion on Investigational Drugs, vol.26, issue.6, pp.821-834, 2009.
DOI : 10.1016/j.jsbmb.2007.09.004

F. Approval, FDA Approves Nexavar for Patients with Inoperable Liver Cancer, 2007.

D. Xu, T. L. Wang, L. P. Sun, and Q. D. You, Mini-Reviews in Medicinal Chemistry, pp.18-31, 2011.

A. Gangjee, S. Kurup, M. A. Ihnat, J. E. Thorpe, S. S. Shenoy et al., Synthesis and biological activity of N4-phenylsubstituted-6-(2,4-dichloro phenylmethyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamines as vascular endothelial growth factor receptor-2 inhibitors and antiangiogenic and antitumor agents, Bioorganic & Medicinal Chemistry, vol.18, issue.10, pp.3575-3587, 2010.
DOI : 10.1016/j.bmc.2010.03.052

A. Gangjee, O. A. Namjoshi, S. N. Keller, C. D. Smith, A. Gangjee et al., 2-Amino-4-methyl-5-phenylethyl substituted-7-N-benzyl-pyrrolo[2,3-d]pyrimidines as novel antitumor antimitotic agents that also reverse tumor resistance, Bioorganic & Medicinal Chemistry, vol.19, issue.14, pp.4355-4365, 2011.
DOI : 10.1016/j.bmc.2011.05.030

Y. Awazu, A. Mizutani, Y. Nagase, H. Iwata, Y. Oguro et al., A novel pyrrolo[3, 2-d]pyrimidine derivative, as a vascular endothelial growth factor receptor and platelet-derived growth factor receptor tyrosine kinase inhibitor, shows potent antitumor activity by suppression of tumor angiogenesis, Cancer Science, vol.9, issue.5, pp.939-944, 2012.
DOI : 10.1126/science.1104819

F. Ballante, D. Corso-di-laurea-in-farmacia-thomae, E. Perspicace, S. Hesse, G. Kirsch et al., QSAR and 3-D QSAR: principles and applications, Tetrahedron, vol.105, issue.643920, pp.9309-9314, 2008.

L. Garuti, M. Roberti, T. Rossi, M. Castelli, and M. Malagoli, Synthesis and antiproliferative activity of 3-substituted 1H-indole [3,2-d]-1,2,3-triazin-4 (3H)-ones, European Journal of Medicinal Chemistry, vol.33, issue.1, pp.43-46, 1998.
DOI : 10.1016/S0223-5234(99)80074-9

L. B. Townsend and L. B. Townsend, Organic Letters, The Journal of Organic Chemistry, vol.115, issue.1414, pp.537-540, 1999.

J. C. Hunt, E. Briggs, E. D. Clarke, and W. G. Whittingham, Synthesis and SAR studies of novel antifungal 1,2,3-triazines, Bioorganic & Medicinal Chemistry Letters, vol.17, issue.18, pp.5222-5226, 2007.
DOI : 10.1016/j.bmcl.2007.06.076

G. Sommen, S. , and N. , Synthèse de thiophènes, sélénophènes, pyrroles et de leurs systèmes condensés à partir de cétènes, Thèse de Doctorat. UPVM, 2007.

D. Thomae, Synthèse d'amino-thiophènes, sélénophènes, thiazoles, application à la synthèse d'analogues hétérocycliques de la Tacrine, Thèse de Doctorat. UPVM, 2008.

E. Migianu, Synthèses d'analogues thiophéniques des paullones, agents antitumoraux potentiels, Thèse de Doctorat. UPVM, 2002.

B. Capon and F. Kwok, The tautomerism of hydroxy derivatives of five-membered oxygen, nitrogen, and sulfur heterocycles, Tetrahedron Letters, vol.27, issue.28, pp.3275-3278, 1986.
DOI : 10.1016/S0040-4039(00)84773-5

C. Corral, J. Lissavetzky, and I. Manzanares, Effects of substituents on the chlorination of methyl 3-hydroxythiophene-2-carboxylate and on the reaction of the resulting chlorinated products with active hydrogen containing compounds, Journal of Heterocyclic Chemistry, vol.89, issue.2, pp.315-319, 1990.
DOI : 10.1002/jhet.5570270237

M. M. Krayushkin, V. Z. Shirinian, D. M. Nikalin, and A. A. Shimkin, Regioselective C-alkylation of alkyl 4-hydroxy-2-methylthiophene-3-carboxylates with ??-halo ketones, Russian Chemical Bulletin, vol.53, issue.3, pp.631-634, 2004.
DOI : 10.1023/B:RUCB.0000035648.41262.77

D. J. Sall, D. R. Berry, W. J. Coffman, T. J. Craft, M. L. Denney et al., Characterization of LY806303 as a potent and selective inhibitor of thrombin, Bioorganic & Medicinal Chemistry Letters, vol.2, issue.9, pp.1025-1028, 1992.
DOI : 10.1016/S0960-894X(00)80611-3

R. Rajagopalan, W. L. Neumann, A. Porredy, J. N. Freskos, R. B. Dorshow et al., WO2010037068(A2) 2010. 141. a) Moursounidis, J Tetrahedron Letters, issue.26, pp.27-3045, 1986.

J. H. Buttery, J. Moursounidis, D. Wege, T. Dey, D. Navarathne et al., A,B-Diheteropentalenes by a Tandem Intramolecular Diels-Alder/Reverse Diels-Alder Reaction Sequence. Application to the Synthesis of Thieno[3,4-b]furan, Targets in Heterocyclic Systems, pp.593-607, 1995.
DOI : 10.1071/CH9950593

A. Prevysh-kvinto, Chemistry of Heterocyclic Compounds, pp.661-664, 1994.

A. Shafiee, M. A. Ebrahimzadeh, J. Shahbazi, and S. Hamedpanah, ]thiazoles, Journal of Heterocyclic Chemistry, vol.62, issue.1, pp.71-75, 1998.
DOI : 10.1002/jhet.5570350114

A. Mateo, M. Camarasa, A. Diaz-ortiz, F. G. De-las-heras, M. Ware et al., Bulletin of the Catalysis Society of India, Journal of the Chemical Society, Chemical Communications Synthetic Communications, vol.147, issue.3221, pp.1114-1115, 1988.

M. Sadeghzadeh, The Journal of Organic Chemistry, pp.9975-9982, 2011.

A. D. Becke, The Journal of Chemical Physics, pp.5648-5652, 1993.

P. C. Hariharan and J. A. Pople, The influence of polarization functions on molecular orbital hydrogenation energies, Theoretica Chimica Acta, vol.53, issue.3, pp.213-222, 1973.
DOI : 10.1007/BF00533485

J. I. Pyo, E. J. Hwang, C. S. Cheong, S. Lee, S. W. Lee et al., Synthesis and photoluminescent properties of novel furopyrimidine derivatives, Synthetic Metals, vol.155, issue.3, pp.461-463, 2005.
DOI : 10.1016/j.synthmet.2005.06.017

J. Lou, Z. Liu, Y. Li, M. Zhou, Z. Zhang et al., Synthesis and anti-tumor activities of N???-benzylidene-2-(4-oxothieno[2,3-d]pyrimidin-3(4H)-yl)acetohydrazone derivatives, Bioorganic & Medicinal Chemistry Letters, vol.21, issue.22, pp.6662-6666, 2011.
DOI : 10.1016/j.bmcl.2011.09.061

B. R. Baker, R. E. Schaub, J. P. Joseph, F. J. Mcevoy, and J. H. Williams, AN ANTIMALARIAL ALKALOID FROM HYDRANGEA. XVIII. DERIVATIVES OF 4-PYRIMIDONE, The Journal of Organic Chemistry, vol.18, issue.2, pp.133-137, 1953.
DOI : 10.1021/jo01130a003

S. Kanawade, P. Nikam, M. Jachak, and R. Toche, Monatshefte für Chemie -Chemical Monthly, pp.317-323, 2012.

C. E. Stephens, T. M. Felder, J. W. Sowell-sr, G. Andrei, J. Balzarini et al., Synthesis and antiviral/antitumor evaluation of 2-amino- and 2-carboxamido-3-arylsulfonylthiophenes and related compounds as a new class of diarylsulfones, Bioorganic & Medicinal Chemistry, vol.9, issue.5, pp.1123-1132, 2001.
DOI : 10.1016/S0968-0896(00)00333-3

B. A. Hathaway, B. E. Taylor, and J. S. Wittenborn, Selective Preparation of 4-(Bromo or Iodo)-2,5-dimethoxybenzonitrile and 2-(Bromo or Iodo)-3,6-dimethoxybenzonitrile from 2,5-Dimethoxybenzaldehyde, Synthetic Communications, vol.6, issue.24, pp.4629-4637, 1998.
DOI : 10.1016/S0040-4039(01)80650-X

P. S. Reddy and C. Nagaraju, A New Synthesis of 2-Aryl-2H-Pyrazino[2,1-B]quinazolin-3,6[1H,4H)-diones, Synthetic Communications, vol.63, issue.2, pp.173-181, 1991.
DOI : 10.1039/p19740002122

S. R. Pattan, V. V. Reddy, F. V. Manvi, B. G. Desai, A. R. Bhat et al., Indian journal of chemistry, pp.1778-1781, 2006.

R. Gompper and W. Breitschaft, Diazachinodimethane, donorsubstituierte Pyrazine und Dihydropyrazine, Angewandte Chemie, vol.22, issue.9, pp.727-729, 1983.
DOI : 10.1002/ange.19670790308

J. Eysseltová and Z. Málková, Solubility in the Systems MCl (M = Na, K)???1,4-Dioxane???Water at 25 ^C, Journal of Solution Chemistry, vol.35, issue.9, pp.1329-1334, 2006.
DOI : 10.1007/s10953-006-9061-x

J. Singh, R. C. Petter, D. Niu, L. Qiao, A. Kluge et al., WO2011034907 (A2) 2011, b) Garcia Ruano, pp.315-317, 2007.

X. He and V. W. Yam, Design, Synthesis, Photophysics, and Ion-binding Studies of a Ditopic Receptor Based on Gold(I) Phosphine Thiolate Complex Functionalized with Crown Ether and Urea Binding Units, Inorganic Chemistry, vol.49, issue.5, pp.2273-2279, 2010.
DOI : 10.1021/ic9021068

T. Horiuchi, J. Chiba, K. Uoto, and T. Soga, Discovery of novel thieno[2,3-d]pyrimidin-4-yl hydrazone-based inhibitors of Cyclin D1-CDK4: Synthesis, biological evaluation, and structure???activity relationships, Bioorganic & Medicinal Chemistry Letters, vol.19, issue.2, pp.305-308, 2009.
DOI : 10.1016/j.bmcl.2008.11.090

F. D. Bellamy and K. Ou, Selective reduction of aromatic nitro compounds with stannous chloride in non acidic and non aqueous medium, Tetrahedron Letters, vol.25, issue.8, pp.839-842, 1984.
DOI : 10.1016/S0040-4039(01)80041-1

Y. Liu, Y. Lu, M. Prashad, O. Repic, and T. J. Blacklock, Advanced Synthesis & Catalysis, pp.217-219, 2005.

X. Liao, X. Zhou, N. Mak, and K. Leung, Tryptanthrin Inhibits Angiogenesis by Targeting the VEGFR2-Mediated ERK1/2 Signalling Pathway, PLoS ONE, vol.303, issue.12, p.82294, 2013.
DOI : 10.1371/journal.pone.0082294.t001

S. V. Chankeshwara and A. K. Chakraborti, -Butyloxycarbonylation of Amines in Water, Organic Letters, vol.8, issue.15, pp.3259-3262, 2006.
DOI : 10.1021/ol0611191

P. Klotz, B. Chatrenet, M. Coppo, B. Rousseau, M. Goeldner et al., Synthesis of a tri-tritiated heterobifunctional reagent, a potential tool in photoaffinity labeling technology, Journal of Labelled Compounds and Radiopharmaceuticals, vol.22, issue.2, pp.149-155, 1991.
DOI : 10.1021/bi00289a012

A. R. Hajipour, S. Safai, and A. E. Ruoho, Oxidation of thiols with methyltriphenylphosphonium dichromate (MTPPD) in dichloromethane at room temperature, Journal of Sulfur Chemistry, vol.96, issue.5, pp.441-444, 2006.
DOI : 10.3184/0308234041209059

Y. Iwakura and S. Izawa, 2-Oxazolidones from Glycidyl Ether Reactions with Acid Amides, Bulletin of the Chemical Society of Japan, vol.39, issue.11, pp.2490-2494, 1966.
DOI : 10.1246/bcsj.39.2490

C. R. Clark and T. W. Davenport, Anticonvulsant Activity of Some 4-Aminophenylacetamides, Journal of Pharmaceutical Sciences, vol.76, issue.1, pp.18-20, 1987.
DOI : 10.1002/jps.2600760106

R. S. Randad, M. A. Mahran, A. S. Mehanna, and D. J. Abraham, Allosteric modifiers of hemoglobin. 1. Design, synthesis, testing, and structure-allosteric activity relationship of novel hemoglobin oxygen affinity decreasing agents, Journal of Medicinal Chemistry, vol.34, issue.2, pp.752-757, 1991.
DOI : 10.1021/jm00106a041

E. Sayed-ramadan, Synthetic Communications, pp.377-382, 2004.